We used two P4HA2 target shRNA sequences to generate stable CRC lines with different efficiencies of P4HA2 depletion (~15% knockdown with shRNA_1 and ~60% knockdown with shRNA_2) (Figures 4A, C). This evidence concerns the gene P4HA2 and colorectal carcinoma.